nivolumab,ipilimumab
bms
['rectal', 'colorectal', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'crcsm', 'niche-2']
#esmo22: niche-2 for tx naive dmmr #colorectalcancer, nonmetastatic, demonstrates &gt; 95% major path response after short term #immunotherapy treatment. look at these waterfall plots! #crcsm #colorectalcancer #cancer #cancerresearch #clinicalresearch 
Co-Director/Co-Leader GI Oncology Research; Director, Young Adult Cancers Program; Co-Chair, NCI GI Steering Committee; and Director for Strategic Relations